MACD(12, 26, 9) Bull Crossover Stocks: AA, FOLD, PG, XBI

NYSE: AA (Alcoa Corporation)

NYSE: AA (Alcoa Corporation) has closed at $47.5, its traded Volume was 5852.94K shares, AA opened the Day at $46.98, it made an intraday Low of $46.53, and an intraday High of $47.95. AA (Alcoa Corporation) 52-week High is $47.95, 52-week Low is: $20, it has supports at $39.59 and $34.43, resistances at $47.95 and $56. AA’s earning is $0.88 per share, Next quarter estimated EPS is $0.98, current year estimated EPS is $2.92. Its PE ratio is 54. Overall, this stock is rated BUY today.

NASDAQ: FOLD (Amicus Therapeutics)

NASDAQ: FOLD (Amicus Therapeutics) has closed at $14.92, its traded Volume was 6051.99K shares, FOLD opened the Day at $13.9, it made an intraday Low of $13.9, and an intraday High of $14.92. FOLD (Amicus Therapeutics) 52-week High is $14.92, 52-week Low is: $4.41, it has supports at $12.76 and $11.43, resistances at $14.92 and $17.42. FOLD’s earning is $-1.47 per share, Next quarter estimated EPS is $-0.28, current year estimated EPS is $-1.37. Its PE ratio is -10. Overall, this stock is rated BUY today.

NYSE: PG (Procter & Gamble Company)

NYSE: PG (Procter & Gamble Company) has closed at $94.4, its traded Volume was 5803.68K shares, PG opened the Day at $94.17, it made an intraday Low of $93.83, and an intraday High of $94.67. PG (Procter & Gamble Company) 52-week High is $94.67, 52-week Low is: $81.18, it has supports at $89.61 and $86.5, resistances at $94.66 and $110.56. PG’s earning is $5.59 per share, Next quarter estimated EPS is $1.15, current year estimated EPS is $4.17. Its PE ratio is 17. Overall, this stock is rated BUY today.

AMEX: XBI (S&P Biotech SPDR)

AMEX: XBI (S&P Biotech SPDR) has closed at $85.17, its traded Volume was 4084.97K shares, XBI opened the Day at $84.03, it made an intraday Low of $83.86, and an intraday High of $85.23. XBI (S&P Biotech SPDR) 52-week High is $85.23, 52-week Low is: $53.15, it has supports at $78.44 and $74.25, resistances at $85.23 and $99.54. XBI’s earning is $0 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is 0. Overall, this stock is rated BUY today.